Joos G - Search Results

1

ERS technical standard on bronchial challenge testing: general considerations and performance of methacholine challenge tests.

Coates AL, Wanger J, Cockcroft DW, Culver BH; Bronchoprovocation Testing Task Force: Kai-Håkon Carlsen; Diamant Z, Gauvreau G, Hall GL, Hallstrand TS, Horvath I, de Jongh FHC, Joos G, Kaminsky DA, Laube BL, Leuppi JD, Sterk PJ. Coates AL, et al. Among authors: joos g. Eur Respir J. 2017 May 1;49(5):1601526. doi: 10.1183/13993003.01526-2016. Print 2017 May. Eur Respir J. 2017. PMID: 28461290 Free article.

2

Direct and indirect bronchial responsiveness.

Joos GF, Kips JC, Pauwels RA. Joos GF, et al. Respir Med. 1993 Aug;87 Suppl B:31-6. doi: 10.1016/0954-6111(93)90123-h. Respir Med. 1993. PMID: 8234966 Review. No abstract available.

3

The effect of inhaled FK224, a tachykinin NK-1 and NK-2 receptor antagonist, on neurokinin A-induced bronchoconstriction in asthmatics.

Joos GF, Van Schoor J, Kips JC, Pauwels RA. Joos GF, et al. Am J Respir Crit Care Med. 1996 Jun;153(6 Pt 1):1781-4. doi: 10.1164/ajrccm.153.6.8665034. Am J Respir Crit Care Med. 1996. PMID: 8665034 Clinical Trial.

4

The effect of ABT-761, a novel 5-lipoxygenase inhibitor, on exercise- and adenosine-induced bronchoconstriction in asthmatic subjects.

Van Schoor J, Joos GF, Kips JC, Drajesk JF, Carpentier PJ, Pauwels RA. Van Schoor J, et al. Among authors: joos gf. Am J Respir Crit Care Med. 1997 Mar;155(3):875-80. doi: 10.1164/ajrccm.155.3.9117020. Am J Respir Crit Care Med. 1997. PMID: 9117020 Clinical Trial.

5

The effect of the NK2 tachykinin receptor antagonist SR 48968 (saredutant) on neurokinin A-induced bronchoconstriction in asthmatics.

Van Schoor J, Joos GF, Chasson BL, Brouard RJ, Pauwels RA. Van Schoor J, et al. Among authors: joos gf. Eur Respir J. 1998 Jul;12(1):17-23. doi: 10.1183/09031936.98.12010017. Eur Respir J. 1998. PMID: 9701408 Free article. Clinical Trial.

6

Ambient ozone concentrations induce airway hyperresponsiveness in some rat strains.

Depuydt P, Joos GF, Pauwels RA. Depuydt P, et al. Among authors: joos gf. Eur Respir J. 1999 Jul;14(1):125-31. doi: 10.1034/j.1399-3003.1999.14a21.x. Eur Respir J. 1999. PMID: 10489839 Free article.

7

Indirect bronchial hyperresponsiveness in asthma: mechanisms, pharmacology and implications for clinical research.

Van Schoor J, Joos GF, Pauwels RA. Van Schoor J, et al. Among authors: joos gf. Eur Respir J. 2000 Sep;16(3):514-33. doi: 10.1034/j.1399-3003.2000.016003514.x. Eur Respir J. 2000. PMID: 11028670 Free article. Review.

8

Effect of inhaled fluticasone on bronchial responsiveness to neurokinin A in asthma.

Van Schoor J, Joos GF, Pauwels RA. Van Schoor J, et al. Among authors: joos gf. Eur Respir J. 2002 Jun;19(6):997-1002. doi: 10.1183/09031936.02.01112001. Eur Respir J. 2002. PMID: 12108885 Free article. Clinical Trial.

9

Indirect airway challenges.

Joos GF, O'Connor B, Anderson SD, Chung F, Cockcroft DW, Dahlén B, DiMaria G, Foresi A, Hargreave FE, Holgate ST, Inman M, Lötvall J, Magnussen H, Polosa R, Postma DS, Riedler J; ERS Task Force. Joos GF, et al. Eur Respir J. 2003 Jun;21(6):1050-68. doi: 10.1183/09031936.03.00008403. Eur Respir J. 2003. PMID: 12797503 Free article.

10

Dual tachykinin NK1/NK2 antagonist DNK333 inhibits neurokinin A-induced bronchoconstriction in asthma patients.

Joos GF, Vincken W, Louis R, Schelfhout VJ, Wang JH, Shaw MJ, Cioppa GD, Pauwels RA. Joos GF, et al. Eur Respir J. 2004 Jan;23(1):76-81. doi: 10.1183/09031936.03.00101902. Eur Respir J. 2004. PMID: 14738235 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

330 results

Search Page